House Bill 2063
115th Congress(2017-2018)
Opioid PACE Act of 2017
Introduced
Introduced in House on Apr 6, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2063
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017
This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.
April 6, 2017
05/01/2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
04/07/2017
Referred to the Subcommittee on Health.
04/06/2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/06/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:36:00 PM